<i>SPON1</i> Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer’s Disease Mouse Model
Alzheimer’s disease (AD) is a complex, age-related neurodegenerative disease that is the most common form of dementia. However, the cure for AD has not yet been founded. The accumulation of amyloid beta (Aβ) is considered to be a hallmark of AD. Beta-site amyloid precursor protein cleaving enzyme 1...
Main Authors: | Soo Yong Park, Joo Yeong Kang, Taehee Lee, Donggyu Nam, Chang-Jin Jeon, Jeong Beom Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1275 |
Similar Items
-
Interaction of Styrylpyridinium Compound with Pathogenic <i>Candida albicans</i> Yeasts and Human Embryonic Kidney HEK-293 Cells
by: Simona Vaitkienė, et al.
Published: (2020-12-01) -
HEK293T Cells with TFAM Disruption by CRISPR-Cas9 as a Model for Mitochondrial Regulation
by: Vanessa Cristina de Oliveira, et al.
Published: (2021-12-01) -
Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy
by: Qu-Lai Tang, et al.
Published: (2021-01-01) -
Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety
by: Aleksi J. Leikas, et al.
Published: (2023-11-01) -
The effects of amyloid beta aggregation on neuronal transcription
by: Jesse St. Jean, et al.
Published: (2023-06-01)